Lisata Therapeutics, Inc. (NASDAQ: LSTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.

Lisata Therapeutics, Inc. (LSTA)

Company Research Source: MarketBeat

Impact Snapshot

Event Time:

LSTA

Last Price

Price Change

Price Change%

Volume Shares

Max Up

Max Down

Volume Ratio

Performance Comparison Updated

Event Day Stock performance from the time of news release until the following 4pm ET market close	Last price at news event	Since Event Multi-day stock performance from the time of the news release
EVENT DAY Stock performance from the time of news release until the following 4pm ET market close	LAST PRICE AT NEWS EVENT	SINCE EVENT Multi-day stock performance from the time of the news release
	Last Price
	VWAP
High:	Max Up	High:
Low:	Max Down	Low:

%	Post news range	%
	Price change
	Price Change Percentage
	S&P 500 (SPX)
%	Volume ratio	%
	Volume
	Ticks
	Avg transaction size

Don't Miss Out On The Next BIG Stock Move

Event day

Event Day Chart will not be displayed beyond 90-day period of the event

Performance since event

Time And Velocity Analysis

Opt-in for LSTA alerts

LSTA News

LSTA Earnings

8/12/24 - Beat

LSTA Analyst Actions

8/13/24 - HC Wainwright

LSTA Sec Filings

Opt-in for
LSTA alerts

from News Quantified

Opt-in for
LSTA alerts

from News Quantified

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Lisata Therapeutics, Inc. (NASDAQ: LSTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.

Opt in for alerts from News Quantifed

Opt in for alerts from News Quantifed

Opt in for alerts from News Quantifed

Opt in for alerts from News Quantifed

Opt in for alerts from News Quantifed